摘要
Epothilone是一类大环内酯类化合物。它们的微管蛋白聚合活性和紫杉醇对微管解聚的抑制作用使其成为新一代抗核药物。其作用机制与紫杉醇相似,可与微管蛋白结合,使癌细胞不能进行有丝分裂,从而导致癌细胞凋亡。在抗肿瘤光谱、抗肿瘤活性、安全性、水溶性和合成方法等方面均优于紫杉醇。它有望发展成为比紫杉醇更有效的抗肿瘤药物。本文对环氧酮D的合成方法和活性进行了综述和分析。
关键词: 环氧酮D,合成,活性,微管,解聚,紫杉醇。
图形摘要
Current Drug Targets
Title:Synthesis and Activity of Epothilone D
Volume: 19 Issue: 15
关键词: 环氧酮D,合成,活性,微管,解聚,紫杉醇。
摘要: Epothilones are a class of macrolide compounds. Their activities of tubulin polymerization and microtubule depolymerization inhibition like paclitaxel make them a new generation of antimitotic drugs. The mechanism of action is similar to that of paclitaxel, which can bind to tubulin and cause cancer cells to fail to undergo mitosis, thereby causing apoptosis in cancer cells. Epothilone is superior to paclitaxel in anti-tumor spectrum, anti-tumor activity, safety, water solubility and synthetic methods. It is expected to develop into a more effective anti-tumor drug than paclitaxel. Herein, the synthesis methods and activity of epothilone D were summarized and analyzed.
Export Options
About this article
Cite this article as:
Synthesis and Activity of Epothilone D, Current Drug Targets 2018; 19 (15) . https://dx.doi.org/10.2174/1389450119666180803122118
DOI https://dx.doi.org/10.2174/1389450119666180803122118 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders
Current Topics in Medicinal Chemistry Hypoxic Regulation of Metastasis via Hypoxia-Inducible Factors
Current Molecular Medicine Focus on the Multimodal Role of Biomarkers in Breast Cancer
Current Pharmaceutical Design Decreased Expression and Altered Methylation of Syncytin-1 Gene in Human Placentas Associated with Preeclampsia
Current Pharmaceutical Design Targeting Drug-Resistant Prostate Cancer with Dual PI3K/mTOR Inhibition
Current Medicinal Chemistry Potential of Selected Antioxidants for Influenza Chemotherapy
Anti-Infective Agents in Medicinal Chemistry Nephrotoxicity of Bisphenol A (BPA) -An Updated Review
Current Molecular Pharmacology Garlic (<i>Allium sativum</i> L.): Its Chemistry, Nutritional Composition, Toxicity, and Anticancer Properties
Current Topics in Medicinal Chemistry Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer
Current Neurovascular Research Psychoimmunological Analysis of Cancer Patients: Correlation with the Prognosis
Current Aging Science Engineered Polymer Nanoplatforms for Targeted Tumor Cells and Controlled Release Cargos to Enhance Cancer Treatment
Current Medicinal Chemistry HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Development of an Intracellular, DNA Methyltransferase-Specific, and Gene-Specific Assay for Studying Dynamic DNA Methylation
Current Pharmaceutical Design Anticipation in Lynch Syndrome: Where We Are Where We Go
Current Genomics CDK Inhibitors: From the Bench to Clinical Trials
Current Drug Targets Cancer Diagnosis Through IsomiR Expression with Machine Learning Method
Current Bioinformatics Mutual Modulation of Femarelle and Vitamin D Analog Activities in Human Derived Female Cultured Osteoblasts
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Inhibition of Autophagy Strengthens Celastrol-Induced Apoptosis in Human Pancreatic Cancer In Vitro and In Vivo Models
Current Molecular Medicine The Role of XRCC4 in Carcinogenesis and Anticancer Drug Discovery
Recent Patents on Anti-Cancer Drug Discovery Heterogeneity in the Pathology and Molecular Biology of Breast Cancer
Current Genomics